Archives

The NorAD – Guanfacine study

28 March 2017

This new study aims to assess whether a medication called Guanfacine can improve thinking, particularly attention, in people with Alzheimer’s Disease when given alongside other standard medication. We caught up with Dr Paresh Malhotra, Chief Investigator on this study, to find out more: What are the main aims of the study? Guanfacine itself is licensed for […]

World’s most in depth study to detect early signs of Alzheimer’s disease

22 August 2016

  A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, is announced today.  The Deep and Frequent Phenotyping study is funded by the National Institute of Health Research and the MRC and hopes to dramatically improve the success rate of […]

The ‘DAPA’ Study

26 February 2016

Exercise benefits a person’s health a great deal, and it can also help to reduce the risk of developing dementia. Researchers now want to know if it can slow the progression of dementia once it has already begun. How it works Dr Sukhi Dosanjh is the manager of DAPA. She explains that they are looking to: “Study […]

The ‘LMTM’ Study

Research into new drugs for treating illnesses can be some of the most exciting studies carried out. Aims of the Study There is a rare form of dementia called Behavioural Frontotemporal Dementia, or bvFTD for short. It can strike anyone between the ages of 20 and 80, but primarily affects those in their 50s. Currently, […]

The ‘IDEAL’ Study

Aims of the Study IDEAL is the first large-scale project of its kind, and what the researchers find out will be used to guide policy and practice for helping people deal with dementia. As we get older we experience various changes in memory and other abilities which can affect our well-being and quality of life. […]

The ‘AFFECT’ Study

The ‘AFFECT’ study is the first large-scale research study that is a collaboration between researchers in Northern Ireland, and staff at the Dementias and Neurodegenerative Specialty  in England. It is also being jointly funded by the Alzheimer’s Society and British Heart Foundation. Did you know that after Alzheimer’s Disease, Vascular Dementia is the most common […]

The ‘ACDC’ Study

The ‘ACDC’ Study is the very first study that hopes to reduce hallucinations that can occur as part of Lewy Body dementias. Aims of the Study People who have Lewy body dementia, either Parkinson’s disease dementia or dementia with Lewy bodies, can have hallucinations. These hallucinations are often visual and may be disturbing for patients. […]

‘Deep and Frequent Phenotyping’

The ‘Deep and Frequent Phenotyping’ Study hopes to produce new ways of diagnosing dementia before symptoms even arise. Aims of the Study We urgently need new and better treatments that can be given to patients as early as possible to prevent brain damage associated with dementia. Researchers want to do studies before brain damage has progressed […]

The ‘CANN’ Study

This study aims to look at how a supplemented diet could help people with Mild Cognitive Impairment. Aims of the Study The overall health benefits of Omega-3, found in fish, and flavanoids – the nutrients in fruit – have been well established. Researchers now want to establish if these compounds could help in the fight against the […]

The Pfizer SAM-760 Study

14 March 2015

More studies are being added to ‘Join dementia research’ all the time – and we’re working hard to connect volunteers with researchers, helping them to collaborate on vital research into dementia. We are focusing on another study that has been recently added, and we are always seeking more people who might be eligible to take […]

1 2
get_header(); ?>

Archives

1 2